Biotech update from Bret Jensen.
Outperforming market in 2017 after 18 month bear Big uptick in M&A in Jan 3 big deals Feb and Mar have been fairly flat Lots of resistance technically Need an uptick in MA or earnings to break through Expect the uptick to happen in MA Watch Trump’s actions and not words Has appointed 2 free market minded people (FDA, Proposed to double fees for drug approval Watching repeal and replace of ACA Needs to happen before tax and regulatory reform Expect the repeal to happen by April or May Ocular Therapeutix (OCUL) Trigger event in July, new product for cataract surgery Insider buying Omerisk (OMER) OMS721 Priced at just over $10 w PTs in the $30 Next trigger event in few years